News
Video
This Week in Ophthalmology: Week of September 29, 2024
Author(s):
This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.
Welcome to the latest edition of This Week in Ophthalmology, a video series highlighting some of the top articles featured on the Ophthalmology Times website.
EyeCon 2024 was recently held at the Hilton Fort Lauderdale Marina on September 27-28. At the event, Dr. Wendy Lee participated in a symposium titled TED in Focus: A Guide to Accurate Diagnosis and Collaborative, Multidisciplinary care for Thyroid Eye Disease.
Watch: Eyecon 2024: Thyroid Eye Disease in focus
David Hutton also had an opportunity to sit down virtually with Dr. David Chin Yee to discuss his EyeCon presentation on what every Optometrist and Ophthalmologist should know about geographic atrophy at Eyecon 2024.
Watch: Eyecon 2024: What every OD and MD should know about geographic atrophy
A team of researchers at UCLA has developed a deep-learning framework that teaches itself quickly to automatically analyze and diagnose MRIs and other 3D medical images – with accuracy matching that of medical specialists in a fraction of the time. There are a few models under development to analyze 3D images, but the investigators noted this new framework has wide adaptability across a range of imaging modalities.
The researchers have studied it with 3D retinal scans (optical coherence tomography) for disease risk biomarkers, ultrasound videos to examine heart function, 3D MRI scans to assess the severity of liver disease, and 3D CT for chest nodule malignancy screening. They note that it offers a foundation that ultimately may be of value in a variety of other clinical settings, and additional studies are planned
Read More: Researchers: New AI model reaches clinical-expert-level accuracy in complex medical scans
In other news, the Wilmer Eye Institute, Johns Hopkins Medicine has received a $10 million donation from James and Heather Gills to establish the James P. Gills Jr., M.D., & Heather Gills Artificial Intelligence Innovation Center at Wilmer. James Gills trained at Wilmer as a resident in the 1960s, and is a renowned surgeon credited with making small incision cataract surgery and intraocular lens implantation the standard of care in cataracts treatment.
Read Now: Wilmer Eye Institute receives $10 million donation from James and Heather Gills
Harrow announced the relaunch of Triesence, a preservative-free synthetic corticosteroid that is approved by the FDA for visualization during vitrectomy and for the treatment of ocular inflammatory conditions that are unresponsive to topical corticosteroids.
